One of the extremely critical challenges in reproductive health is polycystic ovarian syndrome (PCOS). It affects 9-18% of reproductive-aged women and it is prevalent in approximately 80% of infertile anovulatory women. Menstrual disruption, infertility, and pregnancy troubles are the most common reproductive issues linked with PCOS. Regarding management, studies discussing pharmaceutical treatments for reproductive outcomes are still inadequate. To review the published literature in order to evaluate the diagnosis and the management of PCOS. For choosing of articles the PubMed database was employed with the following specifications ((“polycystic ovary syndrome"[Mesh]) AND (“management” [Mesh]) OR (“diagnosis"[Mesh])). Physician awareness, understanding, and alertness to the likelihood of PCOS diagnosis are the most important factors in the diagnosis. Regarding PCOS management, there is no general treatment for PCOS, therefore treatment must always be customized to the specific needs of each patient.
A multidisciplinary team delivering patient-centered treatment is the best way to treat a PCOS case. The initial treatment for PCOS patients ought to be a change in way of life. Metformin is the most widely prescribed medicine for these individuals' metabolic management. It is also thought that inositol treatment might be an option for improvement of metabolism in PCOS women who cannot take metformin. Moreover, oral contraceptives ought to be contemplated for the control of irregular menses and/or medical hyperandrogenism in teenagers with a PCOS diagnostic.
